Item request has been placed!
×
Item request cannot be made.
×
Processing Request
[A new therapeutic possibility for type 2 diabetes: DPP-4 inhibitors (sitagliptin)].
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Abel T;Abel T; Fehér J
- Source:
Orvosi hetilap [Orv Hetil] 2010 Jun 20; Vol. 151 (25), pp. 1012-6.
- Publication Type:
English Abstract; Journal Article; Review
- Language:
Hungarian
- Additional Information
- Transliterated Title:
Uj kezelési lehetoség a 2-es típusú diabetes terápiájában: DPP-4-gátlók (sitagliptin).
- Source:
Publisher: Akademiai Kiado Country of Publication: Hungary NLM ID: 0376412 Publication Model: Print Cited Medium: Print ISSN: 0030-6002 (Print) Linking ISSN: 00306002 NLM ISO Abbreviation: Orv Hetil Subsets: MEDLINE
- Publication Information:
Publication: 2007- : Budapest : Akademiai Kiado
Original Publication: Pest : Markusovszky Lajos
- Subject Terms:
- Abstract:
Type 2 diabetes is a very common worldwide disorder. A good glycemic control is reduce the rates of diabetes associated microvascular and possibly macrovascular complications. Dipeptidyl peptidase-4 (DPP-4) inhibitors such as sitagliptin demonstrate an incretin based, glucose-dependent actions with low risk of hypoglycemia and no weight gain during the treatment of patients with type 2 diabetes.
- Number of References:
20
- Accession Number:
0 (Blood Glucose)
0 (Dipeptidyl-Peptidase IV Inhibitors)
0 (Hypoglycemic Agents)
0 (Pyrazines)
0 (Triazoles)
TS63EW8X6F (Sitagliptin Phosphate)
- Publication Date:
Date Created: 20100604 Date Completed: 20100714 Latest Revision: 20151119
- Publication Date:
20240829
- Accession Number:
10.1556/OH.2010.28910
- Accession Number:
20519186
No Comments.